Anti-angiogenic effects and mechanisms of polysaccharides from Antrodia cinnamomea with different molecular weights

ETHNOPHARMACOLOGICAL RELEVANCE: Antrodia cinnamomea is a popular medicinal mushroom in Taiwan that has been widely used for treatment of various cancers and liver diseases.

AIM OF THE STUDY: This study aimed to investigate the immunomodulatory effect on angiogenesis of polysaccharides from mycelia of Antrodia cinnamomea (PMAC).

MATERIALS AND METHODS: PMAC were extracted in boiling water, precipitated with 95% ethanol, and separated into four different molecular weights (<5, 5-30, 30-100, > 100 kDa). Tube formation and chorioallantoic membrane (CAM) assay were used to determine the in vitro and ex vivo anti-angiogenic effects.

RESULTS: Only the PMAC-mononuclear cells (MNCs)-conditioned medium (CM) with MW > 100 kDa significantly and concentration-dependently decreased the secretion of vascular endothelial growth factor in human leukemia cells and inhibited the matrigel tube formation in human umbilical vein endothelial cells. Similarly only the PMAC-MNC-CM with MW > 100 kDa significantly and concentration-dependently increased the levels of interleukin (IL)-12 and interferon-gamma (IFN-gamma). In addition, the ex vivo CAM assay revealed that only the PMAC with MW>100 kDa significantly and dose-dependently inhibited neovascularization.

CONCLUSIONS: PMAC with MW > 100 kDa are anti-angiogenic in vitro and ex vivo, and the effects are likely through immunomodulation.

Medienart:

E-Artikel

Erscheinungsjahr:

2009

Erschienen:

2009

Enthalten in:

Zur Gesamtaufnahme - volume:123

Enthalten in:

Journal of ethnopharmacology - 123(2009), 3 vom: 25. Juni, Seite 407-12

Sprache:

Englisch

Beteiligte Personen:

Yang, Chih-Min [VerfasserIn]
Zhou, Yu-Jie [VerfasserIn]
Wang, Ran-Juh [VerfasserIn]
Hu, Miao-Lin [VerfasserIn]

Links:

Volltext

Themen:

187348-17-0
82115-62-6
Angiogenesis Inhibitors
Immunologic Factors
Interferon-gamma
Interleukin-12
Journal Article
Plant Extracts
Polysaccharides
Vascular Endothelial Growth Factor A

Anmerkungen:

Date Completed 08.10.2009

Date Revised 01.12.2018

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1016/j.jep.2009.03.034

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM189081864